GSTZ1 genotypes correlate with dichloroacetate pharmacokinetics and chronic side effects in multiple myeloma patients in a pilot phase 2 clinical trial-Reference-Cited by-同舟云学术

GSTZ1 genotypes correlate with dichloroacetate pharmacokinetics and chronic side effects in multiple myeloma patients in a pilot phase 2 clinical trial

Published:2019-10-08 Issue:6 Volume:7 Page:
ISSN:2052-1707
Container-title:Pharmacology Research & Perspectives
language:en
Short-container-title:Pharmacol Res Perspect

Author:

Tian Dan Dan¹,Bennett Samuel K.²^ORCID,Coupland Lucy A.¹^ORCID,Forwood Kathryn²^ORCID,Lwin Yadanar²,Pooryousef Niloofar¹,Tea Illa¹^ORCID,Truong Thy T.³^ORCID,Neeman Teresa⁴^ORCID,Crispin Philip²^ORCID,D’Rozario James²^ORCID,Blackburn Anneke C.¹^ORCID

Affiliation:

1. ACRF Department of Cancer Biology and Therapeutics The John Curtin School of Medical Research The Australian National University Canberra ACT Australia

2. Department of Haematology The Canberra Hospital Garran ACT Australia

3. Joint Mass Spectrometry Facility The Australian National University Acton ACT Australia

4. Statistical Consulting Unit The Australian National University Acton ACT Australia

Funder

Cancer Council ACT

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/prp2.526

Reference41 articles.